SAN FRANCISCO, July 18, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the second quarter 2018 after the close of trading on Wednesday, August 1, 2018. The company’s management […]
Tag: iRhythm
Study Results Show Zio by iRhythm Improves Detection of Asymptomatic Atrial Fibrillation in At-Risk Population
SAN FRANCISCO, July 10, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that results of the mHealth Screening to Prevent Strokes (mSToPS) study, which showed increased detection of asymptomatic atrial fibrillation (AF) in high-risk […]
iRhythm Technologies Names Karim Karti as Chief Operating Officer
SAN FRANCISCO, June 27, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the appointment of Karim Karti to Chief Operating Officer effective July 23, 2018. Karti brings more than 20 years of experience and a […]
iRhythm Release: Research Collaboration Demonstrates Use Of Deep Learning To Develop Expert Level Comprehensive Cardiac Arrhythmia Detection Algorithm
SAN FRANCISCO, July 10, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care announced a collaboration with the Stanford Machine Learning Group that has resulted in the development of a deep learning algorithm capable of expert level […]
New Study Confirms Extended Continuous Cardiac Monitoring is More Efficient than Holter Monitoring for Cryptogenic Stroke Patients
SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced study results presented during the European Stroke Organisation Conference in Prague. Findings reveal that Zio® by iRhythm extended continuous ambulatory monitoring is more […]
Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health Organizations
SAN FRANCISCO, April 10, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the recent publication of two documents in support of extended continuous ambulatory monitoring for arrhythmia detection. The American College of Cardiology (ACC), the American […]